Oppenheimer Reiterates Outperform on enGene Holdings, Raises Price Target to $33
Benzinga Newsdesk 11 months ago
NewsPrice TargetReiterationAnalyst Ratings
Oppenheimer analyst Leland Gershell reiterates enGene Holdings (NASDAQ:ENGN) with a Outperform and raises the price target from $30 to $33.
Oppenheimer analyst Leland Gershell reiterates enGene Holdings (NASDAQ:ENGN) with a Outperform and raises the price target from $30 to $33.